Skip to content
DraconiticResearch
Search Sources API
182,549 studies31 sourcesUpdated 50 min ago
Peer-reviewedCC BYFrontiers in aging neuroscience

Plasma biomarker strategies to reduce diagnostic uncertainty in p-tau217–based assessment of CSF amyloid positivity in secondary-care patients with MCI

1 more authors
  1. 1Araclon Biotech-Grifols , ,
  2. 2Department of Clinical Analysis, Institute of Laboratory Medicine, Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid , ,
  3. 3Department of Neurology, Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid , ,

Related

  1. Bone marrow kinase X-linked in pulmonary diseases: pathogenic gene, diagnostic biomarker, and treatment target—a narrative review
    Translational pediatricsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Surgical resection for indeterminate pulmonary nodules in patients with prior breast cancer: diagnostic value and biomarker reassessment
    Journal of thoracic diseasePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. Barriers to Biomarker-Guided Advanced Breast Cancer Care in India: Diagnostic, Economic, and Implementation Challenges
    Sandeep Jasuja, Rona Joseph P, Rajeev Gupta +1
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Confirmatory biomarker diagnostic studies are not needed when transitioning from NAFLD to MASLD
    Vlad Ratziu, Jérôme Boursier, Victor de Ledinghen +3
    Journal of HepatologyPeer-reviewedLicence not statedFull text111 citedEpidemiology & public healthHAL
  5. Integrative Multi-Omics and Machine Learning Unveil Plakophilin 1 as a Robust Diagnostic Biomarker for Thymoma
    Yunhan Li, Shen Zhang, Qian Gao +8
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{pascuallucas2026plasma,
  title = {{Plasma biomarker strategies to reduce diagnostic uncertainty in p-tau217–based assessment of CSF amyloid positivity in secondary-care patients with MCI}},
  author = {María Pascual-Lucas and Leticia Sarasa and Noelia Fandos and Jorge Loscos and Judith Romero and Adrián Sánchez and Jose Terencio and Isabel Ortega-Madueño and María Cruz Cárdenas and Fernando Cava-Valenciano and María José Gil-Moreno and Jordi A. Matias-Guiu and José Antonio Allué},
  journal = {Frontiers in aging neuroscience},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13655080},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Plasma biomarker strategies to reduce diagnostic uncertainty in p-tau217–based assessment of CSF amyloid positivity in secondary-care patients with MCI
AU  - María Pascual-Lucas
AU  - Leticia Sarasa
AU  - Noelia Fandos
AU  - Jorge Loscos
AU  - Judith Romero
AU  - Adrián Sánchez
AU  - Jose Terencio
AU  - Isabel Ortega-Madueño
AU  - María Cruz Cárdenas
AU  - Fernando Cava-Valenciano
AU  - María José Gil-Moreno
AU  - Jordi A. Matias-Guiu
AU  - José Antonio Allué
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in aging neuroscience
UR  - https://europepmc.org/article/PMC/PMC13655080
SN  - 1663-4365
ER  -